Clinical trial
Evaluation of Injectable Beta- Tricalcium Phosphate as an Occlusive Barrier Membrane in Treatment of Grade ii Furcation Involvement (Clinical and Radiographic Study)
NCT04443972 is registered in ClinicalTrials.gov with Hams Hamed Abdelrahman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Injectable Beta- Tricalcium Phosphate as an Occlusive Barrier Membrane in Treatment of Grade ii Furcation Involvement (Clinical and Radiographic Study)
- Lead sponsor
- Hams Hamed Abdelrahman
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 12, 2018
- Completion date
- February 4, 2020
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.